Literature DB >> 30739321

Response to "Methodological Considerations on CYP2D6 Phenoconversion Due to Drug-Drug Interaction".

Kelsey West1, Andrew A Monte2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30739321      PMCID： PMC6465135          DOI： 10.1002/cpt.1333

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  5 in total

Review 1.  Appropriate phenotyping procedures for drug metabolizing enzymes and transporters in humans and their simultaneous use in the "cocktail" approach.

Authors:  U Fuhr; A Jetter; J Kirchheiner
Journal:  Clin Pharmacol Ther       Date:  2007-02       Impact factor: 6.875

2.  CYP2D6 Genotype Phenotype Discordance Due to Drug-Drug Interaction.

Authors:  Andrew A Monte; Kelsey West; Kyle T McDaniel; Hania K Flaten; Jessica Saben; Shelby Shelton; Farah Abdelmawla; Lane R Bushman; Kayla Williamson; Diana Abbott; Peter L Anderson
Journal:  Clin Pharmacol Ther       Date:  2018-07-25       Impact factor: 6.875

3.  An optimized methodology for combined phenotyping and genotyping on CYP2D6 and CYP2C19.

Authors:  W J Tamminga; J Wemer; B Oosterhuis; J P Brakenhoff; M G Gerrits; R A de Zeeuw; L F de Leij; J H Jonkman
Journal:  Eur J Clin Pharmacol       Date:  2001-05       Impact factor: 2.953

4.  In-vivo phenotyping for CYP3A by a single-point determination of midazolam plasma concentration.

Authors:  Y S Lin; G F Lockwood; M A Graham; W R Brian; C M Loi; M R Dobrinska; D D Shen; P B Watkins; G R Wilkinson; E D Kharasch; K E Thummel
Journal:  Pharmacogenetics       Date:  2001-12

5.  High-sensitivity liquid chromatography-tandem mass spectrometry for the simultaneous determination of five drugs and their cytochrome P450-specific probe metabolites in human plasma.

Authors:  Kyung-Suk Oh; Su-Jin Park; Dhananjay D Shinde; Jae-Gook Shin; Dong-Hyun Kim
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2012-03-19       Impact factor: 3.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.